State IL
Clinical Trials in Illinois
Recruiting clinical trials with at least one study location in Illinois. Data updated daily from ClinicalTrials.gov.
Top Conditions in Illinois
NCT04462770 Phase 3
Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrom...
Condition
Dravet Syndrome
Enrollment
150 pts
Location
United States, Canada, Georgia
Sponsor
Epygenix
NCT05063331 N/A
Recruiting
Patient-Centered Outcomes in the Surgical Treatment of Uterovaginal Prolapse
Condition
Uterine Prolapse
Enrollment
320 pts
Location
United States
Sponsor
University Hospitals Cleveland
NCT06384079 N/A
Recruiting
Duration of Ureteral Rest Prior to Ureteral Reconstruction Surgery
Condition
Ureteral Stricture
Enrollment
25 pts
Location
United States
Sponsor
Northwestern University
NCT07364773 N/A
Recruiting
Enhancing Rehabilitation Participation in Patients With SCI/D Using Motivational...
Condition
Spinal Cord Injuries (SCI)
Enrollment
180 pts
Location
United States
Sponsor
Shirley Ryan AbilityLab
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
NCT03193151 N/A
Recruiting
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
Condition
Liver Dysfunction
Enrollment
300 pts
Location
United States, Australia, Canada
Sponsor
University of Alberta
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT06066502 Phase 3
Recruiting
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
Condition
Acute Respiratory Distress Syndrome
Enrollment
1,100 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
NCT04572451 Phase 1
Recruiting
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metasta...
Condition
Melanoma
Enrollment
50 pts
Location
United States
Sponsor
Yana Najjar
NCT05278039 N/A
Recruiting
Training Swallowing Initiation During Expiration
Condition
Head and Neck Cancer
Enrollment
88 pts
Location
United States
Sponsor
Northwestern University
NCT05863195 Phase 3
Recruiting
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus St...
Condition
Metastatic Colorectal Carcinoma
Enrollment
408 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT05898594 N/A
Recruiting
Lung Cancer Screening in High-risk Black Individuals
Condition
Lung Cancer
Enrollment
900 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT06395519 Phase 1, Phase 2
Recruiting
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Condition
Advanced or Metastatic Solid Tumors
Enrollment
120 pts
Location
United States
Sponsor
858 Therapeutics, Inc.
NCT05966194 Phase 2
Recruiting
RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radia...
Condition
Oral Mucositis
Enrollment
216 pts
Location
United States
Sponsor
EpicentRx, Inc.
NCT04479072 Phase 4
Recruiting
Aspirin and Preeclampsia
Condition
Preeclampsia Postpartum
Enrollment
180 pts
Location
United States
Sponsor
University of Chicago
NCT07174583 Phase 1, Phase 2
Recruiting
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell L...
Condition
Small-cell Lung Cancer
Enrollment
208 pts
Location
United States, Australia, Brazil
Sponsor
IDEAYA Biosciences
NCT06957366 N/A
Recruiting
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patien...
Condition
Atrial Fibrillation (AF)
Enrollment
920 pts
Location
United States, Belgium, Canada
Sponsor
McMaster University
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT05687123 Phase 1
Recruiting
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera)...
Condition
Metastatic Pancreatic Neuroendocrine Tumor
Enrollment
24 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT06618794 N/A
Recruiting
Recovery Legal Care Clinical Trial
Condition
Firearm Injury
Enrollment
500 pts
Location
United States
Sponsor
University of Chicago
NCT03587272 Phase 2
Recruiting
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children ...
Condition
Sickle Cell Disease
Enrollment
100 pts
Location
United States, Canada
Sponsor
Robert Nickel
NCT05985161 Phase 2
Recruiting
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Condition
Wilms Tumor
Enrollment
45 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05230173 N/A
Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remi...
Condition
Ulcerative Colitis
Enrollment
250 pts
Location
United States
Sponsor
University of California, San